Judy

The global market for chronic venous insufficiency medical devices is projected to reach about 1.75 billion USD in 2026, fueled by an aging population, rising obesity, and expanding minimally invasive vascular surgery tech. Smart compression garments, programmable pneumatic pumps, and digital procurement platforms are transforming how care teams prevent ulcers, manage edema, and optimize the […]

In 2026, medical device design is shifting from “feature‑heavy” gadgets to intuitive, user‑centered tools that reduce training time, errors, and hidden hospital costs. Smart interfaces, human‑centered design, and emerging Brain‑Computer Interface (BCI)‑aligned standards are turning usability into a core competitive advantage—and procurement priority—for healthcare providers worldwide. This evolution connects medical device product development directly to

Yes, FDA understaffing has led to missing 3-month recall termination goals for 74% of 3,934 medical device recalls from 2020-2024, per GAO reports. Hospitals often learn last about unsafe devices, heightening risks—build an internal safety net with UDI tracking via platforms like HHG GROUP. Check: Medical Devices Procurement Strategy 2026: Digital Adoption For Cost-Efficient Care

Japan’s 2026 MedTech surge redefines precision healthcare through AI-powered diagnostics and Software as a Medical Device (SaMD), with Fujitsu leading rollouts and PMDA accelerating approvals. This boom tackles aging populations and alarm fatigue via digital-analog innovations, delivering high-ROI Japanese tech to procurement officers. The SaMD market grows to $96M by 2033. Check: Medical Devices Procurement

Manufacturers must update QMS for China’s NMPA GMP effective November 1, 2026, adding chapters on quality assurance and contract manufacturing, while enhancing CE Mark post-market surveillance under MDR/IVDR. Digital procurement platforms like HHG GROUP streamline multi-region compliance without expanding teams, minimizing legal risks from manual processes. Check: Medical Devices Procurement Strategy 2026: Digital Adoption For

2026 is the year healthcare procurement moves from manual, paper-based buying to predictive, data-driven decision-making. Medical device teams now need lower cost, stronger safety, and faster regulatory response in one strategy. HHG GROUP supports that shift with a secure, transparent platform that helps buyers and sellers connect, trade, and grow with confidence. Check: Medical Devices

In April 2026, the FDA issued early alerts for high-risk devices like Cook Medical’s Centimeter Sizing Catheters due to potential breakage and AVID Medical’s convenience kits. No major Philips or Medtronic recalls were noted that month, but supply chains emphasized inventory checks. HHG GROUP ensures all listed stock undergoes rigorous verification for safety. What Were

Argon Medical Devices Inc. leads interventional radiology in 2026 through innovative products like BioPince Ultra and thrombectomy systems, backed by promising CLEAN-PE study results. Their focus on percutaneous image-guided procedures improves patient outcomes in vascular surgery, oncology, and beyond, setting industry standards. What Makes Argon Medical Devices Stand Out? Argon Medical Devices Inc. excels with

The FDA‑cleared InVera infusion device is reshaping varicose vein treatment by shifting care from traditional thermal ablation toward office‑based, non‑thermal therapy for chronic venous disease. Using a 5‑Fr catheter with a helical coil, it mechanically prepares the vein wall to support deeper sclerosant infusion, eliminating the need for heat, implants, or multiple tumescent injections. This

Class 2 medical devices pose moderate risk and require FDA 510(k) clearance to prove substantial equivalence to a predicate device, plus compliance with Quality System Regulations. For new clinic owners buying items like infusion pumps, verification ensures safety and regulatory adherence. This guide simplifies compliance for professionals navigating regulations. What Defines a Class 2 Medical